{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:45:52Z","timestamp":1792003552965,"version":"4.4.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Retinal neovascularization is a common feature of several ocular neovascular diseases, which are the leading cause of blindness in the world. Current treatments are administered through invasive intravitreal injections, leading to poor patient compliance, serious ocular complications and heavy economic burdens. Thus, an alternative less or non-invasive therapeutic strategy is in demand. Here, a non-invasive oral tyrosine kinase inhibitor, CM082, was evaluated in a retinal neovascularization model induced by hypoxia in zebrafish larvae. We found that CM082 effectively suppressed retinal neovascularization, rescued cell loss in the retinal ganglion cell layer, and rescued the visual function deficiency. Our results elucidated that CM082 mediated its therapeutic efficacy primarily through the inhibition of Vegfr2 phosphorylation. The findings demonstrated that CM082 possessed strong antiangiogenic effects and may serve as a potential treatment for angiogenesis in ocular neovascular diseases.<\/jats:p>","DOI":"10.3389\/fphar.2024.1336249","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T04:22:16Z","timestamp":1722226936000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["CM082 suppresses hypoxia-induced retinal neovascularization in larval zebrafish"],"prefix":"10.3389","volume":"15","author":[{"given":"Jun-long","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-gang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1471-213X-7-114","article-title":"Genetic determinants of hyaloid and retinal vasculature in zebrafish","volume":"7","author":"Alvarez","year":"2007","journal-title":"BMC Dev. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00280-022-04406-6","article-title":"Phase 1b trial of anti-VEGF\/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors","volume":"89","author":"Bagegni","year":"2022","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1242\/dev.01970","article-title":"Genetic and cellular analyses of zebrafish atrioventricular cushion and valve development","volume":"132","author":"Beis","year":"2005","journal-title":"Development"},{"key":"B5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/PPO.0000000000000138","article-title":"The contribution of angiogenesis to the process of metastasis","volume":"21","author":"Bielenberg","year":"2015","journal-title":"Cancer J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e888","DOI":"10.1016\/S2214-109X(17)30293-0","article-title":"Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis","volume":"5","author":"Bourne","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.survophthal.2017.08.008","article-title":"The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: a review","volume":"63","author":"Bracha","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","article-title":"Molecular pathogenesis of retinal and choroidal vascular diseases","volume":"49","author":"Campochiaro","year":"2015","journal-title":"Prog. Retin Eye Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2748","DOI":"10.1371\/journal.pone.0002748","article-title":"Hypoxia-induced retinal angiogenesis in zebrafish as a model to study retinopathy","volume":"3","author":"Cao","year":"2008","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/nprot.2010.149","article-title":"Hypoxia-induced retinopathy model in adult zebrafish","volume":"5","author":"Cao","year":"2010","journal-title":"Nat. Protoc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/CIA.S151225","article-title":"Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis","volume":"13","author":"Cui","year":"2018","journal-title":"Clin. Interv. Aging"},{"key":"B12","doi-asserted-by":"publisher","first-page":"104146","DOI":"10.1016\/j.mvr.2021.104146","article-title":"CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo","volume":"136","author":"Dan","year":"2021","journal-title":"Microvasc. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1200\/JCO.2002.10.088","article-title":"Vascular permeability factor\/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy","volume":"20","author":"Dvorak","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"19126","DOI":"10.1073\/pnas.0709337104","article-title":"OFF ganglion cells cannot drive the optokinetic reflex in zebrafish","volume":"104","author":"Emran","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3791\/923","article-title":"A behavioral assay to measure responsiveness of zebrafish to changes in light intensities","author":"Emran","year":"2008","journal-title":"J. Vis. Exp."},{"key":"B17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ajo.2021.11.015","article-title":"Real-world visual outcomes of laser and anti-VEGF treatments for retinopathy of prematurity","volume":"238","author":"Gundlach","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"D758","DOI":"10.1093\/nar\/gkw1116","article-title":"The Zebrafish Model Organism Database: new support for human disease models, mutation details, gene expression phenotypes and searching","volume":"45","author":"Howe","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnbeh.2018.00053","article-title":"Zebrafish lacking circadian gene per2 exhibit visual function deficiency","volume":"12","author":"Huang","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/jamaophthalmol.2017.1571","article-title":"Oral tyrosine kinase inhibitor for neovascular age-related macular degeneration: a phase 1 dose-escalation study","volume":"135","author":"Jackson","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12861-015-0066-9","article-title":"Development and origins of zebrafish ocular vasculature","volume":"15","author":"Kaufman","year":"2015","journal-title":"BMC Dev. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/aja.1002030302","article-title":"Stages of embryonic development of the zebrafish","volume":"203","author":"Kimmel","year":"1995","journal-title":"Dev. Dyn."},{"key":"B23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.mod.2009.01.002","article-title":"Small molecule screen for compounds that affect vascular development in the zebrafish retina","volume":"126","author":"Kitambi","year":"2009","journal-title":"Mech. Dev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1083\/jcb.200602080","article-title":"Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments","volume":"174","author":"Lampugnani","year":"2006","journal-title":"J. Cell Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.omto.2022.01.001","article-title":"Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity","volume":"24","author":"Liang","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ncb2679","article-title":"Spatial regulation of VEGF receptor endocytosis in angiogenesis","volume":"15","author":"Nakayama","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1038\/s41433-020-01384-y","article-title":"Efficacy of bevacizumab for vitreous haemorrhage in proliferative diabetic retinopathy with prior complete panretinal photocoagulation","volume":"35","author":"Park","year":"2021","journal-title":"Eye (Lond)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ebiom.2017.12.014","article-title":"A vascular endothelial growth factor-dependent sprouting angiogenesis assay based on an in vitro human blood vessel model for the study of anti-angiogenic drugs","volume":"27","author":"Pauty","year":"2018","journal-title":"EBioMedicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1007\/s10637-021-01093-7","article-title":"Vorolanib (X-82), an oral anti-VEGFR\/PDGFR\/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study","volume":"39","author":"Pedersen","year":"2021","journal-title":"Invest. New Drugs"},{"key":"B32","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nm.3849","article-title":"Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization","volume":"21","author":"Rama","year":"2015","journal-title":"Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6145651","DOI":"10.1155\/2017\/6145651","article-title":"The effect of CM082, an oral tyrosine kinase inhibitor, on experimental choroidal neovascularization in rats","volume":"2017","author":"Ren","year":"2017","journal-title":"J. Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1167\/iovs.04-0682","article-title":"Contrast sensitivity, spatial and temporal tuning of the larval zebrafish optokinetic response","volume":"46","author":"Rinner","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/jb\/mvs136","article-title":"Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases","volume":"153","author":"Shibuya","year":"2013","journal-title":"J. Biochem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.21147\/j.issn.1000-9604.2021.01.11","article-title":"Vorolanib, an oral VEGFR\/PDGFR dual tyrosine kinase inhibitor for treatment of patients with advanced solid tumors: an open-label, phase I dose escalation and dose expansion trial","volume":"33","author":"Song","year":"2021","journal-title":"Chin. J. Cancer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.drudis.2010.12.004","article-title":"Drug delivery to the posterior segment of the eye","volume":"16","author":"Thrimawithana","year":"2011","journal-title":"Drug Discov. Today"},{"key":"B38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.survophthal.2004.06.002","article-title":"Macular edema","volume":"49","author":"Tranos","year":"2004","journal-title":"Surv. Ophthalmol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1242\/dmm.004036","article-title":"von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish","volume":"3","author":"Van Rooijen","year":"2010","journal-title":"Dis. Model Mech."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/iovs.62.2.5","article-title":"VEGFR2 trafficking by KIF13B is a novel therapeutic target for wet age-related macular degeneration","volume":"62","author":"Waters","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0126750","DOI":"10.1371\/journal.pone.0126750","article-title":"Hypoxia-induced retinal neovascularization in zebrafish embryos: a potential model of retinopathy of prematurity","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.omto.2019.12.007","article-title":"CM082 enhances the efficacy of chemotherapeutic drugs by inhibiting the drug efflux function of ABCG2","volume":"16","author":"Xu","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"B43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.drudis.2020.09.034","article-title":"3D engineering for optic neuropathy treatment","volume":"26","author":"Xuan","year":"2021","journal-title":"Drug Discov. Today"},{"key":"B44","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fncel.2018.00348","article-title":"Hypoxia delays oligodendrocyte progenitor cell migration and myelin formation by suppressing Bmp2b signaling in larval zebrafish","volume":"12","author":"Yang","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.molmed.2015.12.007","article-title":"Cell-based therapy for degenerative retinal disease","volume":"22","author":"Zarbin","year":"2016","journal-title":"Trends Mol. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/1759-7714.13430","article-title":"CM082, a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non-small cell lung cancer in vitro and in vivo","volume":"11","author":"Zhang","year":"2020","journal-title":"Thorac. Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrd3745","article-title":"Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma","volume":"11","author":"Zhang","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e0149663","DOI":"10.1371\/journal.pone.0149663","article-title":"A naturally-derived compound schisandrin B enhanced light sensation in the pde6c zebrafish model of retinal degeneration","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1634\/theoncologist.2014-0465","article-title":"Targeting angiogenesis in cancer therapy: moving beyond vascular endothelial growth factor","volume":"20","author":"Zhao","year":"2015","journal-title":"Oncologist"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1336249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T04:22:18Z","timestamp":1722226938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1336249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":49,"alternative-id":["10.3389\/fphar.2024.1336249"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1336249","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"article-number":"1336249"}}